Brits first to trial AstraZeneca's 'antibody cocktail' for weak immune systems
Reading now: 304
dailystar.co.ukThe Daily Star's FREE newsletter is spectacular! Sign up today for the best stories straight to your inboxTrials for AstraZeneca's highly-anticipated coronavirus 'antibody cocktail' are starting in the UK - and it could prevent the virus from developing for up to a year.The treatment is designed for those whose weakened immune systems mean they cannot be vaccinated, but an 'antibody cocktail' could protect against Covid-19 infection for up to a year.A participant in Manchester will be the first in the world to take the pharmaceutical company's treatment which will be trialled on 1,000 volunteers from nine sites in the UK.Another 4,000 participants will come from Europe and the United States.Unlike a vaccine, the drug aims to introduces.
Read more on dailystar.co.uk
The website celebsbar.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
